Skip to content
Home/Companies/Biotech/Bambusa Therapeutics
BT

Bambusa Therapeutics

Biotech·United States·Active·1yr hold

Bambusa Therapeutics is a biotech company, headquartered in United States.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Bambusa Therapeutics?

Bambusa Therapeutics is currently owned by Athos through Athos Evergreen Life Sciences (2001 vintage), since 2025.

Hand-verified · updated 2026-07-07

Athos
Investor
Athos
Athos Evergreen Life Sciences · 2001 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Athos Evergreen Life Sciences

Other portfolio companies in the same fund.

Doctolib
Active
FintechFrance· 2026
AAVantgarde Bio
Active
BiotechItaly· 2025
AMSilk
Active
BiotechGermany· 2025
Antheia
Active
BiotechUnited States· 2025
NexWafe
Active
EnergyGermany· 2023
Formycon
Active
BiotechGermany· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings